Panacea Biotec Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on September 30, 2025
PANACEABIO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Panacea Biotec held its 41st Annual General Meeting on September 30, 2025, at 11:30 AM via video conferencing. The meeting was chaired by Mr. Mukul Gupta, a Non-Executive Independent Director, as Chairman and Managing Director Dr. Rajesh Jain could not attend. Shareholders considered ordinary business items including adoption of audited standalone and consolidated financial statements for FY ending March 31, 2025, and re-appointment of Dr. Rajesh Jain and Mr. Sandeep Jain as directors. Special business included appointment of R&D Company Secretaries as Secretarial Auditors and ratification of remuneration of the Cost Auditors for FY2025-26. The Statutory and Secretarial Auditors' reports contained no qualifications or adverse remarks. The consolidated voting results and Scrutinizer's Report are to be submitted by October 3, 2025.
This is a routine regulatory disclosure of AGM proceedings with no material business impact. Shareholders should watch for the voting results due by October 3, 2025, which will confirm approval of the financial statements and director re-appointments.